Evofem Biosciences, Inc.
EVFM
Revenue
4.83M
▲3.98M▲471.01%
3 Months ChangeAssets
14.38M
▲1.51M▲11.69%
3 Months ChangeLiabilities
79.21M
▲1.53M▲1.97%
3 Months ChangeFree Cash Flow
109.00k
▲5.05M▲102.21%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001493152-24-043241
2024-10-28
Form 8-K
ID: 0001493152-24-042605
2024-10-03
Form 8-K
ID: 0001493152-24-039392
2024-09-25
Form 8-K
ID: 0001493152-24-038113
2024-09-06
Form 8-K
ID: 0001493152-24-035285
2024-08-30
Form 8-K
ID: 0001493152-24-034623
2024-08-20
Form 8-K
ID: 0001493152-24-033265
2024-08-14
Form 10-Q
ID: 0001493152-24-031846
2024-08-14
Form 8-K
ID: 0001493152-24-031835
2024-07-23
Form 8-K
ID: 0001493152-24-028818